zanamivir has been researched along with s 8932 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Dong, R; Liu, G; Lu, Q; Peng, L; Tian, G; Wang, J; Yang, J; Zhou, L | 1 |
2 other study(ies) available for zanamivir and s 8932
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Drug Evaluation, Preclinical; Host-Pathogen Interactions; Humans; Molecular Docking Simulation; Oseltamivir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Zanamivir | 2020 |